US$ 25.79
tirzepatide peak sales GLP-1 Weight Loss Drug Market Size, Share weight management Archives - Drug
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] Associated Data This section collects any data citations, data availability statements, or supplementary materials included in this article.

Compound details
Retatrutide is the new kid on the block

In 2024, SAXENDA generated sales of USD 345 million in the US

This synergistic fat metabolism effect is the primary reason tirzepatide outperforms semaglutide in every head-to-head trial conducted to date

According to FDA prescribing information, anti-tirzepatide antibodies develop in a minority of patients receiving the medication
